David Sinclair on Joe Rogan: NAD+, NMN & Cellular Longevity Breakdown (2026)

I've followed David Sinclair's work for the better part of a decade — read Lifespan twice, tracked his lab's papers, and watched every one of his Joe Rogan appearances. So I went into episode #2537 with high expectations, and he cleared them. This was not a supplement-hawking victory lap. It was a Harvard geneticist laying out, in plain language, one of the most consequential ideas in modern biology: that aging is not simple wear and tear, but a loss of information inside your cells — and that information may be recoverable.

I'm Kim, founder of Elemental Edge, and I'm 51. I build this company around a simple belief: the science of getting stronger and sharper after 40 is real, and it deserves to be explained with both rigor and excitement. Sinclair's research earns both. What follows is the deep version of what he covered — the information theory of aging, sirtuins and NAD+, NMN, the Yamanaka-factor reprogramming that let his lab restore sight in blind mice, and the daily habits he runs himself. I'll tell you what's proven, what's the frontier, and where the boring foundational basics fit while the frontier catches up.

The Information Theory of Aging

Here is Sinclair's central thesis, and it is a genuinely beautiful piece of thinking. Your body stores two kinds of information. The first is digital — the DNA sequence itself, the four-letter code, which is remarkably stable over a lifetime. The second is analog — the epigenome, the pattern of chemical marks that sits on top of your DNA and decides which genes are switched on in which cell. A liver cell and a neuron carry identical DNA; what makes them different is the epigenetic pattern telling each one which genes to read.

Sinclair argues that we age because the analog information degrades. Every time your cells repair a DNA break, the repair crew has to leave its post on the epigenome to go fix the damage — and it doesn't always return to exactly the right spot. Over decades, those tiny misplacements accumulate as epigenetic noise, and cells slowly forget their identity. His analogy on Rogan was the one he's used for years: a scratched DVD. The music — the data — is still there. The player just can't read it cleanly anymore.

What lifts this from philosophy to science is that his lab built a way to test it. In a striking set of experiments (the "ICE" mouse study published in Cell in 2023), his team induced harmless DNA breaks to deliberately scramble the epigenome without changing the DNA sequence — and the mice aged faster on multiple measures. Then, using cellular reprogramming, they pushed some of that aging back. That's the part worth sitting with: it suggests aging carries a backup copy of youthful information the cell can be coaxed to read again. This is frontier work, largely in mice so far, and that is exactly what makes it one of the most exciting programs in biology right now.

The full conversation: Joe Rogan Experience #2537 with Dr. David Sinclair.

Sirtuins and NAD+: the longevity enzymes

If the epigenome is the software, sirtuins are part of the maintenance crew that keeps it clean. Sinclair's career was built on this family of enzymes — seven of them in humans, SIRT1 through SIRT7 — that quiet down unwanted genes, help repair DNA, and coordinate the cell's response to stress. They are, in a real sense, guardians of cellular identity.

Here is the hinge of the whole story: sirtuins cannot work without a molecule called NAD+ (nicotinamide adenine dinucleotide). NAD+ is a mandatory co-substrate — the fuel the enzyme literally consumes to do its job. And NAD+ is also spent by other emergency systems. When DNA is damaged, an enzyme called PARP1 fires up to help repair it, and PARP1 burns through enormous amounts of NAD+ in the process. So DNA damage and sirtuin maintenance are drawing from the same tank.

The problem with age is simple to state: NAD+ levels fall. The decline is well documented in the peer-reviewed literature (see this 2021 review in Nature Reviews Molecular Cell Biology). As the tank drains, sirtuins get less fuel, repair competes harder for what's left, and the epigenome accumulates noise faster. Restore NAD+, the thinking goes, and you give the maintenance crew its fuel back. That hypothesis is the engine behind the entire NAD+ supplement field.

NMN, NR, and how cells actually take it up

You can't usefully swallow NAD+ directly — the molecule is large and gets broken down before it reaches your cells. So the strategy is to supply a precursor, a building block the cell can convert into NAD+ internally. The two most discussed are NMN (nicotinamide mononucleotide), which Sinclair takes himself, and NR (nicotinamide riboside). NR is one step further back in the pathway; the cell converts NR into NMN, then NMN into NAD+. Both feed the same reservoir by slightly different routes.

One detail Sinclair has highlighted is how NMN gets into the cell. His collaborators reported a dedicated transporter, Slc12a8, that ferries NMN directly across the cell membrane — a finding that would help explain how oral NMN could raise NAD+ systemically. It's worth being straight with you: that transporter result has been actively debated by other labs, and the human clinical picture for NMN is still early — small, short trials showing it reliably raises NAD+ markers, without yet proving it extends human healthspan or lifespan. That's not a knock. It's where a genuinely new science sits before the big trials read out, and it's why watching this space is so interesting.

Yamanaka factors (OSK) and reversing cellular age

This is the part of the episode that gives me chills every time. In 2006, Shinya Yamanaka showed that four genes could turn an adult cell all the way back into a stem cell — winning a Nobel Prize for it. The catch is that full reprogramming erases the cell's identity entirely, which is not what you want in a living tissue. Sinclair's insight was to ask: what if you use only three of those factors — Oct4, Sox2, and Klf4, together called OSK — and only for a while? Could you rewind a cell's age without erasing what it is?

The answer, in his lab's 2020 Nature paper, was yes — at least in mice. They delivered OSK to the eye using a harmless virus and restored vision in old and injured mice, regenerating optic-nerve cells that mammals aren't supposed to be able to regrow. On Rogan he described extending the same approach to other organs, including reversing fatty liver disease by retargeting the delivery to the liver. He measures the rejuvenation with DNA methylation "aging clocks," the same molecular clocks Steve Horvath pioneered.

Read that in full: a therapy that makes aged cells behave young again, demonstrated in a mammal, measured on a molecular clock. It is early, it is mostly animal work, and the safety bar for humans is high — reprogramming has to stop short of cancer risk. But "we restored sight by resetting cellular age" is not hype. It's a published result, and it reframes what "treating aging" could eventually mean.

A word on the man behind the work

I'll be honest about my bias: I admire Sinclair, and I've also read his critics. He's polarizing — he has commercial interests in this field, and serious scientists have pushed back on how far ahead of the human data his optimism can run. I don't wave that away. But I keep coming back to this: he chose one of the hardest, least fashionable problems in biology and spent decades on it, and the ideas above — information theory, resetting a cell's age — are his fingerprints on the field. You can hold both at once: clear-eyed about the hype cycle, and glad someone with his talent is aiming at the target. His lab publishes its work openly if you want to follow the research itself.

It's also fair to say this kind of science is chronically underfunded. Regulators still don't classify aging itself as a treatable condition, so the basic study of why we age competes for scraps against disease-by-disease budgets — and Sinclair has spent years arguing to change that. Fundamental research like his runs on grants and philanthropy, not product sales, and it moves in decades. If the ideas pan out, the payoff isn't a supplement; it's a different relationship with age itself. That's worth rooting for, even from the sidelines.

Sinclair’s own daily protocol

Across his books, his interviews, and this conversation, Sinclair has described a remarkably consistent personal routine. He's careful to call it his own N-of-1 experiment rather than a prescription, and I'll echo that hard: several pieces below involve prescription drugs or are unproven for healthy people, so treat this as a window into his thinking, not a shopping list.

• NAD+ precursors: he takes NMN daily, aiming to keep his NAD+ reservoir topped up.
• Plant molecules: resveratrol (taken with a fat source for absorption) as a sirtuin-supporting compound, and interest in senolytics like fisetin that help clear worn-out "zombie" cells. Human evidence here is mixed and still developing.
• Metformin: he has discussed taking this prescription diabetes drug for its metabolic and possible longevity effects. Important: it's being formally studied for aging (the TAME trial) but is not approved or proven for that use, and it's not something to start without a physician.
• Hormetic stress: regular exercise, time-restricted eating, and deliberate temperature and low-oxygen stress — the "what doesn't kill you" signals that switch on the cell's own defense and repair programs.
• A low-sugar, mostly plant-forward diet and a general strategy of keeping the body a little bit challenged rather than constantly comfortable.

The through-line is coherent: keep NAD+ available, trigger the body's stress-defense pathways, and avoid the metabolic noise that accelerates epigenetic drift. You don't need a prescription or an experimental compound to act on most of that principle. You need the fundamentals handled first.

The foundational bridge: what you can do today

Here's where I connect the frontier to the floor. Sinclair's reprogramming work may reach clinics in the next decade. Meanwhile, every one of the mechanisms he describes — DNA repair, sirtuin activity, mitochondrial energy — runs on machinery that needs ordinary, proven nutrients to function. Restoring NAD+ does nothing if the repair enzymes it powers are short on their own cofactors, or if the cell can't make enough ATP to run the process. This is the unglamorous foundation, and it's the part I actually formulate. It is ours, not Sinclair's, and he doesn't endorse it — but the biology is the same biology.

Magnesium glycinate. DNA repair isn't only about NAD+. The enzymes that physically rebuild the strand — the polymerases and ligases — are magnesium-dependent, and magnesium is a required cofactor in over 300 enzymatic reactions, including the ATP metabolism that repair runs on. In the glycinate form it's well absorbed and calming, which is why I use it for sleep — and deep sleep is when a great deal of cellular repair actually happens. It supports the crew NAD+ pays.

Micronized creatine. Sinclair keeps returning to energy — failing mitochondria, cells that can't power their own upkeep. Creatine is the most studied way to keep phosphocreatine topped up, the system that rapidly regenerates ATP in muscle and brain. A systematic review of randomized trials found a real cognitive signal, strongest exactly when the brain is energy-stressed. Repair and maintenance are expensive; creatine helps keep the cell solvent. More in our creatine and brain health guide.

Vitamin D3. Vitamin D behaves less like a vitamin and more like a hormone: through its receptor it influences the expression of a very large number of genes across immunity, muscle, and cellular housekeeping. Deficiency is common past 40 and worth correcting to a normal range — a floor for the system, not a megadose. Think of it as keeping the genome's day-to-day signaling well-supplied.

The honest framing: these three won't reprogram your cells. They keep the repair, energy, and signaling systems that Sinclair's science depends on running while the frontier matures. If you want that floor handled in one decision, that's what our 90-Day Foundation system is for.

Cellular longevity biomarkers after 40: what depletes them vs. what supports them

This table describes normal cellular biology and general nutrition. It is not a treatment protocol or a claim to slow, stop, or reverse aging.

Our take, in video

Elemental Edge masterclass: building a cellular baseline that holds.

Frequently asked questions

What did David Sinclair say on Joe Rogan about NAD+?

Sinclair frames NAD+ as the essential fuel for the sirtuin enzymes that maintain the epigenome and assist DNA repair, and he notes that NAD+ falls with age — draining the system that keeps cells youthful. He takes the precursor NMN himself to help restore it. The age-related NAD+ decline is well established; the claim that boosting it extends human lifespan is the exciting, still-unproven frontier being tested in trials now.

How does cellular saturation support longevity?

"Saturation" means keeping the cell's working reservoirs — NAD+ precursors, plus the everyday nutrients like creatine, magnesium, and vitamin D that its repair and energy machinery depends on — consistently topped up, so nothing runs short when the cell needs to maintain itself. It's the daily foundation beneath the more speculative reprogramming science: keep the fuel and cofactors available, and the maintenance systems can do their job.

What supplements does David Sinclair take?

Based on his public statements, Sinclair's personal regimen has centered on the NAD+ precursor NMN, resveratrol (taken with a fat source), vitamin D3, and the prescription drug metformin, alongside exercise, a low-sugar diet, and time-restricted eating. It's his own experiment, not a recommendation — metformin requires a prescription, and several of these compounds are still unproven for longevity in humans. Treat it as informative, not prescriptive.

Is NMN safe, and does it actually work?

Short-term human trials suggest NMN is well tolerated and can raise NAD+ markers in the blood. What they have not yet shown is that it extends human lifespan or reverses aging — those claims are still waiting on larger, longer studies. Promising and apparently low-risk in the short term, but not a proven anti-aging therapy. If you're considering it, talk to your doctor, especially if you take medication.

Can aging really be reversed?

In the lab, in animals, partly — and that's the genuinely stunning part. Sinclair's team reset the biological age of cells and restored vision in mice using partial reprogramming. In living humans, no: there's no approved therapy that reverses aging today, and the safety hurdles (including cancer risk) are significant. The honest status is a real, measurable proof of concept in mice, and a long road of human trials ahead.

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. This article is educational commentary on public science and is not medical advice. Consult a qualified healthcare provider before starting any supplement or making changes to your regimen, especially if you take medication or have a health condition.